BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heo JY, Seo YB, Choi WS, Lee J, Yoon JG, Lee SN, Choi MJ, Noh JY, Ahn JY, Jeong HW, Cheong HJ, Kim WJ, Lee HY, Song JY. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis. PLoS One 2018;13:e0194598. [PMID: 29596444 DOI: 10.1371/journal.pone.0194598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Ding H, Huang J, Ngai CH, Sun Q, Kwok K, Wang HH, Chong M, Wong MC. The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.01.033] [Reference Citation Analysis]
2 Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Review of Respiratory Medicine 2018;13:63-77. [DOI: 10.1080/17476348.2019.1555040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
3 Guo W, Yi L, Wang P, Wang B, Li M. The effect of air temperature on hospital admission of adults with community acquired pneumonia in Baotou, China. Sci Rep 2021;11:9353. [PMID: 33931697 DOI: 10.1038/s41598-021-88783-7] [Reference Citation Analysis]
4 Choi MJ, Kang SO, Oh JJ, Park SB, Kim MJ, Cheong HJ. Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea. Hum Vaccin Immunother 2018;14:1914-22. [PMID: 29953307 DOI: 10.1080/21645515.2018.1456602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 Ferreira-Coimbra J, Sarda C, Rello J. Burden of Community-Acquired Pneumonia and Unmet Clinical Needs. Adv Ther 2020;37:1302-18. [PMID: 32072494 DOI: 10.1007/s12325-020-01248-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
6 Kang J, Kim EH, Ihn K, Jung I, Han M, Ahn JG. Risk of invasive pneumococcal disease in patients with asplenia/hyposplenism: A nationwide population-based study in Korea, 2009–2018. International Journal of Infectious Diseases 2020;98:486-93. [DOI: 10.1016/j.ijid.2020.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tantawichien T, Hsu LY, Zaidi O, Bernauer M, Du F, Yamada E, Kim JO, Sukarom I. Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas. Expert Rev Vaccines 2021;:1-12. [PMID: 34894996 DOI: 10.1080/14760584.2022.2016399] [Reference Citation Analysis]
8 LeBlanc J, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang AL, Gillis HD, Martin I, Demczuk WH, LaFerriere C, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA. Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015. BMJ Open Respir Res 2020;7:e000550. [PMID: 32188585 DOI: 10.1136/bmjresp-2019-000550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 Choi MJ, Noh JY, Cheong HJ, Kim WJ, Kim MJ, Jang YS, Lee SN, Choi EH, Lee HJ, Song JY. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS One 2019;14:e0210520. [PMID: 30699137 DOI: 10.1371/journal.pone.0210520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Perniciaro S, van der Linden M. Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study. Lancet Reg Health Eur 2021;7:100126. [PMID: 34557837 DOI: 10.1016/j.lanepe.2021.100126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chien YC, Lee YL, Liu PY, Lu MC, Shao PL, Lu PL, Cheng SH, Lin CY, Wu TS, Yen MY, Wang LS, Liu CP, Lee WS, Shi ZY, Chen YS, Wang FD, Tseng SH, Chen YH, Sheng WH, Lee CM, Chen YH, Ko WC, Hsueh PR. National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020. J Glob Antimicrob Resist 2021;26:308-16. [PMID: 34289409 DOI: 10.1016/j.jgar.2021.07.005] [Reference Citation Analysis]
12 Heo JY, Seo YB, Choi WS, Kim EJ, Jeong HW, Lee J, Yoon JG, Noh JY, Cheong HJ, Kim WJ, Song JY. Effectiveness of Pneumococcal Vaccination Against Hospitalized Pneumococcal Pneumonia in Older Adults: A Prospective, Test-Negative Study. J Infect Dis 2021:jiab474. [PMID: 34537847 DOI: 10.1093/infdis/jiab474] [Reference Citation Analysis]
13 Jeon I, Jung GP, Seo HG, Ryu JS, Han TR, Oh BM. Proportion of Aspiration Pneumonia Cases Among Patients With Community-Acquired Pneumonia: A Single-Center Study in Korea. Ann Rehabil Med 2019;43:121-8. [PMID: 31072078 DOI: 10.5535/arm.2019.43.2.121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Heo JY, Song JY. Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines. Infect Chemother 2018;50:287-300. [PMID: 30600652 DOI: 10.3947/ic.2018.50.4.287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Han JW, Song H, Kim SH. The association between L1 skeletal muscle index derived from routine CT and in-hospital mortality in CAP patients in the ED. Am J Emerg Med 2021;42:49-54. [PMID: 33450707 DOI: 10.1016/j.ajem.2020.12.064] [Reference Citation Analysis]
16 Koo BS, Lim YC, Lee MY, Jeon JY, Yoo HJ, Oh IS, Shin JY, Kim TH. The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors. Mod Rheumatol 2021;:1-14. [PMID: 33494621 DOI: 10.1080/14397595.2021.1878985] [Reference Citation Analysis]
17 Heo JY, Seo YB, Jeong HW, Choi MJ, Min KH, Choi WS, Lee J, Noh JY, Cheong HJ, Kim WJ, Song JY. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines. Vaccine 2020;38:7747-55. [PMID: 33164798 DOI: 10.1016/j.vaccine.2020.10.046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]